What is Miron Smelt used for?

Miron Smelt

Active Ingredient:: Mirtazapine
Origin:: EU

Miron Smelt (Mirtazapine)

Mirtazapine, the active ingredient in Miron Smelt, is a NaSSA (noradrenergic and specific serotonergic antidepressant) presented as an oral dosage form for oral use. It is indicated for the treatment of major depressive disorder in adult patients. It is formulated for systemic absorption and is marketed across the European Union.

GNH India supplies Miron Smelt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and export regulations. The company provides comprehensive logistics support, including customs clearance and temperature‑controlled shipping where required.

Manufacturer / TM Owner

Teva B.V

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mirtazapine is used primarily in the management of depressive disorders, acting on noradrenergic and serotonergic pathways.

Major depressive disorder: reduces depressive symptoms and improves mood in adult patients.
Depressive episodes in bipolar disorder (adjunct): alleviates depressive phase when used alongside mood stabilizers.
Depression with insomnia: helps improve sleep quality while treating depressive symptoms.

How It Works

Mirtazapine antagonizes central presynaptic α2‑adrenergic receptors, leading to increased release of norepinephrine. It also blocks postsynaptic 5‑HT2 and 5‑HT3 receptors, enhancing serotonergic transmission through 5‑HT1 receptors. By inhibiting these receptors, mirtazapine reduces inhibitory feedback on noradrenergic neurons and modulates serotonin pathways, resulting in increased neurotransmitter availability in key brain regions involved in mood regulation. This pharmacodynamic profile underlies its clinical efficacy in depressive states.

Side Effects

Mirtazapine may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects

Sedation: drowsiness or sleepiness, especially at treatment initiation.
Increased appetite/weight gain: heightened hunger leading to weight increase.
Dry mouth: reduced salivation causing oral discomfort.
Constipation: slowed gastrointestinal motility.

Serious or Rare Side Effects

Agranulocytosis: severe reduction in white blood cells requiring medical attention.
Severe neutropenia: markedly low neutrophil count increasing infection risk.
Suicidal thoughts: emergence or worsening of suicidal ideation, particularly early in therapy.

Precautions & Warnings

When prescribing mirtazapine, clinicians should observe several safety considerations.

Monitor weight: patients may experience significant weight gain.
Assess suicidality: watch for emergence of suicidal thoughts, especially in early treatment.
Use caution in hepatic impairment: dose adjustment may be needed for liver dysfunction.
Adjust in renal impairment: consider renal function when dosing.
Avoid abrupt discontinuation: taper gradually to reduce withdrawal symptoms.
Store at room temperature: keep in the original container, protect from moisture.

Avoid Interactions

Mirtazapine can interact with other medicines, and some combinations should be avoided.

Major Interactions (Avoid)

MAO inhibitors: concurrent use can cause hypertensive crisis or serotonin syndrome.
SSRIs or SNRIs: combined serotonergic activity raises risk of serotonin syndrome.
Linezolid: may precipitate serotonin syndrome when used together.

Moderate Interactions (Monitor Closely)

Benzodiazepines: additive central nervous system depression may increase sedation.
Alcohol: concurrent use can enhance sedative effects and impair cognition.

Frequently Asked Questions

Miron Smelt contains the antidepressant mirtazapine and is prescribed for the treatment of major depressive disorder in adult patients. It helps alleviate depressive symptoms such as

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 12 Sep 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.